INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Aug 28, 2020 |
Director
Trans History: 60
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $25.45 | 41,433 |
| Aug 28, 2020 |
Director
Trans History: 60
|
Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | -- |
| Feb 26, 2020 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 38,079 |
| Feb 26, 2020 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $52.03 | 36,380 |
| Feb 12, 2020 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $52.03 | 36,380 |
| Feb 12, 2020 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 63,079 |
| May 13, 2019 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $52.03 | 47,450 |
| May 13, 2019 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | -- | 98,079 |
| Dec 16, 2015 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 25,000 | -- | 25,000 |
| Nov 05, 2015 |
EVP Research and Development
Trans History: 660
|
EVP Research and Development | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 25,000 | $21.25 | 78,377 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.